ProteiNext 2025: Gene Therapy Analytical Development Symposium

Welcome to ProteiNext Symposium, proudly brought to you by Bio-Techne.

With a focus on protein analysis, ProteiNext is an annual symposium that offers a platform for sharing insights, overcoming challenges, and driving meaningful progress in the field.

This year, we shine a spotlight on Gene Therapy Analytical Development —a field that is transforming the landscape of medicine and treatment. We invite industry experts to join us to discuss the complexities and challenges in gene therapy analytical development. The sessions will cover topics such as the development of robust analytical platforms, challenges in gene transfer and delivery systems, protein characterization in gene therapy products, and regulatory considerations that impact the field. Special emphasis will be placed on optimizing analytical strategies for gene therapy quality control, as well as ensuring consistency, safety, and efficacy.

Join us as we embark on a journey of exploration, innovation, and discovery at ProteiNext. Together, let's push the boundaries of possibility and shape the future of protein science.

 

Key Learnings:

Gain insights into the latest analytical strategies for critical quality attribute analysis for gene therapy development, including protein characterization, vector stability assessment, and delivery system optimization.
Learn from industry experts tackling real-world challenges in gene therapy analytical development and explore innovative solutions driving the field forward.
Understand regulatory considerations and quality control measures essential for ensuring consistency, safety, and efficacy in gene therapy development.

Ana Carreras Gonzalez
R&D Analytical Development Scientist, Viralgen
Benjamin Hall
Senior Scientist, Tessera Therapeutics
Chris Heger, Ph.D.
Director, Application Sciences, Bio-Techne
David Hermanson
Principal Scientist, Cell & Gene Therapy, Bio-Techne
Gabriel Vasquez
Specialist II, MilliporeSigma
Louis Szeponik, Ph.D.
Senior Scientist, Discovery Imaging Sciences, AstraZeneca, Sweden
Nicolas Tricaud, Ph.D.
Co-founder, CEO/CSO, Nervosave Therapeutics
Priyalakshmi Panikker, Ph.D.
Asst. Principal Investigator, GROW Laboratory, Narayana Nethralaya
Ryan McComb, Ph.D.
Product Manager, Cellular Analysis, Bio-Techne
William Wood
Analytical Lead, Cell and Gene Therapy Catapult
Zusen Weng
Sr. Scientist, Applications and Business Development, Bio-Techne China

 

    Location: Virtual
    X
    Contact Us

    Complete one of the three forms below and we will get back to you.

    For Quote Requests, please provide more details in the Contact Sales form below

    Advanced Cell Diagnostics

    Our new headquarters office starting May 2016:

    7707 Gateway Blvd.  
    Newark, CA 94560
    Toll Free: 1 (877) 576-3636
    Phone: (510) 576-8800
    Fax: (510) 576-8798

     

    Bio-Techne

    19 Barton Lane  
    Abingdon Science Park
    Abingdon
    OX14 3NB
    United Kingdom
    Phone 2: +44 1235 529449
    Fax: +44 1235 533420

     

    Advanced Cell Diagnostics China

    20F, Tower 3,
    Raffles City Changning Office,
    1193 Changning Road, Shanghai 200051

    021-52293200
    info.cn@bio-techne.com
    Web: www.acdbio.com/cn

    For general information: Info.ACD@bio-techne.com
    For place an order: order.ACD@bio-techne.com
    For product support: support.ACD@bio-techne.com
    For career opportunities: hr.ACD@bio-techne.com